VC-Verzeichnis

Europäisches VC-Verzeichnis

Kuratierter Index aktiver Venture-Capital-Fonds in Europa und Israel. Verfolge Investoren, Phasen und Ticketgrößen.

CAAP Creation

Frankreich
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CAIVE

Europa
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CAMPO

Deutschland
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CAPNOVA

Aarhus, DK
C

CAPNOVA (formerly Østjysk Innovation) historically focused on investing state-backed capital in early-stage, innovative startups in Region Midtjylland, particularly those connected to local universities or research institutions. Post-2018, it transitioned to an exit operator role for its legacy portfolio before shifting to a management role for the Midtjysk Iværksætterfond (MIF). Current direct investments are limited to Resother Pharma and Clearview Trade.

Seed/Pre-seedEarly-stage innovative startups with regional (Midtjylland) tiesoften linked to academic institutions

CARB-X

Boston, USA

CARB-X is a global non-profit partnership accelerating the development of antibacterial products to combat drug-resistant bacteria. Their focus is on funding and supporting projects with diverse approaches and mechanisms of action, specifically targeting the most serious resistant bacteria identified on global priority lists and syndromes with the greatest global morbidity and mortality. CARB-X provides non-dilutive funding, scientific, regulatory, and business support to product developers, focusing on both therapeutics and preventatives from early lead discovery through preclinical development and into Phase 1 clinical trials, as well as diagnostics from feasibility through prototype development. CARB-X fills a critical gap in antibiotic development, addressing the antibiotic resistance crisis driven by bacterial evolution, antibiotic overuse, and poor economic incentives for antibiotic development. They are committed to stewardship and access, ensuring the availability and responsible use of new products globally, particularly in low- and middle-income countries (LMICs). This includes requiring product developers to create Stewardship and Access Plans, outlining strategies for responsible stewardship and access. CARB-X also embraces an “aligned-by-design” model for diagnostics, where investment must meet the needs of the CARB-X-funded therapeutic and prevention portfolio. CARB-X’s strategy is designed to create efficiencies across multiple product developers. Portfolio Acceleration Tools (PATs) were launched in 2020 to improve understanding of common development issues, and potentially generate funding calls around focused areas of innovation and development. The outcomes generated from the PATs are intended to benefit the larger AMR community.

Early development, preclinical development, Phase 1 clinical trials, prototype developmentAntibioticspreventatives

CASRA Capital

C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CATRON Holding

Bonn, Deutschland

Based on the provided text, CATRON Holding appears to be a domain marketplace rather than a venture capital firm. The content focuses on selling premium domains and highlighting customer testimonials related to domain purchases. There is no mention of investments, portfolio companies, or an investment philosophy. The primary business seems to revolve around facilitating the buying and selling of domain names, offering services such as domain transfers and customer support. The geographic focus is implied to be Germany, given the use of German language, references to German companies, and the presence of a German phone number.

Not applicableDomain namesdigital assets

CBDSI GmbH

Deutschland
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CCI

C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CDPQ

Montréal, CA

Based on the website content, CDPQ (Caisse de dépôt et placement du Québec) operates as a global investment group. Their strategy appears to focus on long-term investments across various sectors, both within Quebec and internationally. The firm's activity highlights include investments in data centers tailored for AI, real estate, and infrastructure, along with participation in acquisitions and divestitures. The emphasis on Quebec-based companies suggests a commitment to fostering local economic growth. CDPQ seems to be looking for sustainable investments.

Not mentionedData centersArtificial Intelligence

CDTI Innovación

ES
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CDTM Venture Fund

Munich, Deutschland

The CDTM Venture Fund is a venture capital firm that invests in early-stage companies founded by alumni of the Center for Digital Technology & Management (CDTM). The fund aims to provide capital and support to empower the next generation of founders, fueling innovation and strengthening the CDTM community. Backed exclusively by CDTM alumni, the fund leverages a powerful network of experienced entrepreneurs, operators, and investors to support its portfolio companies. A portion of the fund's profits are donated to support current CDTM students, creating a cycle of giving back to future innovators. The firm's investment strategy focuses on providing early capital at attractive terms to CDTM founders. This exclusive funding opportunity, coupled with the extensive support from the CDTM network, offers a unique advantage to portfolio companies. The fund's team of experienced professionals provides expertise and network access to help founders navigate the challenges of building and scaling their businesses. Furthermore, the firm is committed to fostering a strong sense of community and collaboration within the CDTM ecosystem. By investing in CDTM founders, the CDTM Venture Fund aims to generate financial returns while also contributing to the growth and development of the CDTM community. The fund's unique structure and focus on CDTM alumni create a strong alignment of interests and a powerful platform for supporting the next generation of innovators. The team is dedicated to providing capital, expertise, and network access to help CDTM founders build successful and impactful companies.

Early stageNot mentioned

CEA Investissement

Paris, Frankreich

CEA Investissement was created in 1999 as CEA Valorisation, a wholly-owned subsidiary of CEA, to support its policy of creating businesses. In 2008, it became CEA Investissement with the objective of taking direct stakes in companies leveraging CEA technologies, targeting patent valorization and investments in start-ups. Their specific aims include investing during the start-up creation phase (taking founder shares) based on innovations linked to CEA research, supporting the scientific and commercial development of young companies originating from the CEA's spin-off policy or connected through research contracts, benefiting from financial returns in case of success, and maintaining control, even indirectly, over technologies originating from CEA laboratories. Beyond participating in creation, CEA Investissement has developed an investment activity in the best projects in its portfolio, supporting the initial rounds of many companies. In 2013, with the implementation of new state support mechanisms for start-up seed funding (Fonds National d’Amorçage), CEA Investissement initiated the raising of its first seed fund, ATI (Amorçage Technologique Investissement). CEA Investissement is the primary subscriber to this fund, alongside Bpifrance and several industrial partners, providing CEA-related start-ups with enhanced support opportunities in their initial development phases. In partnership with Amundi (Groupe Crédit Agricole), and leveraging its investment team's expertise, CEA Investissement created Supernova Invest in 2017, an AMF-approved management company. This was done to develop its fund-of-funds activity and expand its intervention capabilities towards deeptech start-ups originating from the CEA or the best French laboratories, at all development stages. CEA Investissement invests in the Supernova 2 (75 M€), Supernova Innovation 3 (74 M€) seed funds, and the Supernova Ambition Industrie growth fund which closed in 2023 at 204 M€. Through these "fund of funds" interventions, CEA Investissement has the capacity to support start-ups valorizing CEA technologies, from their creation to growth capital, including seed and private equity stages. Since 1999, CEA Investissement has financed and supported around a hundred start-ups, following the CEA's innovation policy across life sciences, energy, microelectronics, materials, and industrial equipment.

Pre-seed, Seed, GrowthLife sciencesenergy

CEECAT Capital

London, Großbritannien

CEECAT Capital is a private equity investment manager focused on investing in small and mid-market companies in Emerging Europe and Turkey. They aim to create long-term value for their investors by investing in and promoting the growth of their portfolio companies. The firm emphasizes responsible and sustainable growth, promoting socially responsible practices, corporate governance, and focusing on the impact of their companies on their carbon footprint, diversity, and involvement in local communities. CEECAT works with CEOs and management teams to develop concrete plans to effect meaningful and lasting change in their communities and the wider environment. Their investment strategy involves growth equity investments in Southeast Emerging Europe, focusing on majority buyout or minority investments with significant control rights. They look for financially sustainable companies where they see an opportunity to grow organically and/or through acquisitions. The firm targets regional champions, supporting themes driven by core convergence, export competitiveness, and import substitution in the fast-growing Eastern European markets. CEECAT Capital is committed to ESG principles and strives towards the “International Finance Corporation’s Performance Standards on Social and Environmental Sustainability.” They take a disciplined approach to identifying risks as part of their ESG screening, conducting detailed due diligence as part of the risk evaluation. Post-investment, they aim to build capacity at the portfolio company for the control and mitigation of potential risks and overall improvement in the company's ESG practices. They are a signatory to the Principles of Responsible Investment (PRI). CEECAT II Fund invests in companies with 30-100% shareholding, focusing on ultimate control. The target investment period is 5 years.

Growth Equity, BuyoutIndustrialsBusiness Services

CEED Bulgaria

BG
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CEMAG Invest

Frankreich
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CF Private Equity

C

CF Private Equity (formerly Commonfund Capital) has a long history in private equity investing, dating back to 1988. Their investment philosophy centers around three pillars: access, values, and results. They aim to provide sophisticated investors with access to capacity-constrained and difficult-to-access venture capital and private equity firms, leveraging their decades-long relationships. Rooted in its parent company, Commonfund's, founding mission to help colleges fund their educational mission, CF Private Equity emphasizes a values-led organization committed to trust, transparency, and ethical behavior. Ultimately, they strive to exceed investor expectations by delivering strong results and providing proactive, hands-on service. CF Private Equity employs diverse and dynamic investing strategies across buyouts and growth equity, venture capital, real assets, and sustainability. They construct strategy-specific portfolios using a mix of primaries, secondaries, and co-investments, focusing on smaller and growing companies backed by sector and geographic specialist general partners. They also directly invest into private companies through co-investments and are active in the secondaries market. The firm's investment approach also emphasizes innovation and a commitment to proactive risk management, as evidenced by their early adoption of various alternative strategies like real assets, secondary investments, and co-investments. Their experience spans various geographies, including Europe and emerging markets. CF Private Equity targets pension funds, endowments, foundations, family offices, investment advisors, and other sophisticated investors seeking to diversify their portfolios with private investments. The firm's ability to leverage their long-standing relationships within the private equity world, combined with their commitment to both investment acumen and ethical conduct, positions them as a valuable partner for both investors and fund managers. The firm is also differentiated by it's early embrace of co-investments and secondaries.

Not explicitly mentioned but inferred to be growth, expansion and potentially late-stage ventureBuyoutsGrowth Equity

CFFI UK Ventures (Barbados) Ltd

BB
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CFT Capital Ltd

FI
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CFT Nordic Capital Ltd

FI
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CH-1 Investment Group

C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CIV

Europa
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CLP

Hong Kong
C

Venture-Capital-Firma, die in wachstumsstarke Technologieunternehmen investiert.

CNI

Stockholm, Schweden

Based on the website content, CNI focuses on taking "exceptional businesses to the next level." They seem to invest in companies with strong founding teams and innovative solutions within their respective industries. The portfolio companies highlighted suggest a preference for companies disrupting traditional markets or creating new categories, as indicated by investments in areas like digital invoicing, SME lending, personalized fitting technology, expense management, digital storytelling, and mobile pharmacy. The quotes from founders indicate a focus on companies that are building the future and reshaping their markets. CNI's investment strategy seems to involve partnering with founders to support their growth and development. While the specific details of their approach are not explicitly stated, the emphasis on "taking businesses to the next level" suggests a hands-on approach that extends beyond simply providing capital. This likely includes strategic guidance, operational support, and access to their network. The diversity of industries represented in the portfolio suggests that CNI is sector-agnostic within technology-driven or digitally-enabled businesses but they appear to consistently seek ventures with high growth potential. They focus on transformative and innovative models across industries. CNI appears to primarily support expansion and market leadership opportunities for companies that already have traction, aligning the firm as an active partner to scale strong business models and support the execution of ambitious visions.

Not explicitly mentioned, but portfolio companies suggest Series A and growth stagesFintechSME Lending